SCHEMBL18034495

SCHEMBL18034495

CC(CO)c1oc(=O)cc2c1[C@@H](O)C1OC(=O)[C@@]3(C)C[C@@H](O)C[C@@]2(C)C13

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ MITF O75030 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ NFKB2 Q00653 1/20 0.60
▸ RELA Q04206 1/20 0.60
▸ POLB P06746 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496584 0.89 LMNA (0.74) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL18034509 0.89 LMNA (0.74) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL18034496 0.82 LMNA (0.69) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL18034494 0.77 LMNA (0.74) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL29709864 0.75 LMNA (1.00) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL18290307 0.75 LMNA (1.00) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL29709820 0.75 LMNA (0.84) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL30496607 0.75 LMNA (0.56) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL18034518 0.73 LMNA (0.76) LMNAHTTSMN1; SMN2NPC1MITF
SCHEMBL30496592 0.72 LMNA (0.53) LMNAHTTSMN1; SMN2NPC1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016131426-A1 NAGILACTONE COMPOUNDS HAVING ANTILIPEMIC ACTIVITY, PREPARATION METHOD THEREFOR AND USES THEREOF 中国科学院上海药物研究所 2016-08-25 — — WO disclosed
Send feedback